These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Clozel M, Watanabe H. Life Sci; 1993; 52(9):825-34. PubMed ID: 8437512 [Abstract] [Full Text] [Related]
3. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Zhang Y, Oliver JR, Horowitz JD. Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310 [Abstract] [Full Text] [Related]
4. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Warner TD, Allcock GH, Vane JR. Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643 [Abstract] [Full Text] [Related]
8. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F. Eur J Pharmacol; 1992 Oct 06; 221(1):77-83. PubMed ID: 1459192 [Abstract] [Full Text] [Related]
9. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus. Hay DW, Luttmann MA, Beck G, Ohlstein EH. Br J Pharmacol; 1996 Jul 06; 118(5):1209-17. PubMed ID: 8818345 [Abstract] [Full Text] [Related]
10. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Allcock GH, Warner TD, Vane JR. Br J Pharmacol; 1995 Nov 06; 116(5):2482-6. PubMed ID: 8581288 [Abstract] [Full Text] [Related]
12. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Seo B, Oemar BS, Siebenmann R, von Segesser L, Lüscher TF. Circulation; 1994 Mar 06; 89(3):1203-8. PubMed ID: 8124808 [Abstract] [Full Text] [Related]
14. Cerebral postischemic hypoperfusion is mediated by ETA receptors. Spatz M, Yasuma Y, Strasser A, McCarron RM. Brain Res; 1996 Jul 08; 726(1-2):242-6. PubMed ID: 8836568 [Abstract] [Full Text] [Related]
16. Ketanserin reduces neuronal calcium accumulation and cell death in the hippocampus of the Mongolian gerbil after transient forebrain ischemia. Klisch J, Bode-Greuel KM. Brain Res; 1992 Apr 24; 578(1-2):1-7. PubMed ID: 1511266 [Abstract] [Full Text] [Related]
17. Endothelin antagonists diminish postischemic microvascular incompetence and necrosis in the heart. Maxwell L, Harrison WR, Gavin JB. Microvasc Res; 2000 Mar 24; 59(2):204-12. PubMed ID: 10684726 [Abstract] [Full Text] [Related]
18. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats. Ikeda S, Awane Y, Kusumoto K, Wakimasu M, Watanabe T, Fujino M. J Pharmacol Exp Ther; 1994 Aug 24; 270(2):728-33. PubMed ID: 8071866 [Abstract] [Full Text] [Related]
19. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro. D'Orléans-Juste P, Yano M, Maurice MC, Gratton JP. J Cardiovasc Pharmacol; 1995 Aug 24; 26 Suppl 3():S369-72. PubMed ID: 8587417 [Abstract] [Full Text] [Related]